ArticleNanomaterials (Basel, Switzerland)2025
Efficient Removal of Micro-Sized Degradable PHBV Microplastics from Wastewater by a Functionalized Magnetic Nano Iron Oxides-Biochar Composite: Performance, Mechanisms, and Material Regeneration.
Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Engineered biochar as a powerful tool for microplastics removal from wastewater: a critical review.Environmental geochemistry and health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The co-occurrence of the synthesis of a functionalized magnetic nano iron oxides-biochar composite (MFe@BC) via impregnation-thermal pyrolysis and its use to remove micro-sized poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) microplastics from simulated wastewater was demonstrated in this study. The results showed that PHBV removal efficiency correlated positively with MFe@BC dosage, achieving an adsorption capacity of 13.14 mg/g and a removal efficiency of 98.53% at an optimal dosage of 1.5 g/L. Adsorption kinetics fit a pseudo-second-order model (R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.